• 1. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 2. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 3. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 4. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 5. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551

Benzeneacetic acid,4-(2-hydroxyethoxy)- (CAS No: 132004-29-6): A Comprehensive Overview in Modern Chemical Biology

Benzeneacetic acid,4-(2-hydroxyethoxy)-, identified by its unique Chemical Abstracts Service (CAS) number 132004-29-6, represents a compound of significant interest in the realm of chemical biology and pharmaceutical research. This molecule, characterized by its benzeneacetic acid backbone modified with a 2-hydroxyethoxy substituent, has garnered attention due to its structural versatility and potential biological activities. The integration of hydroxyl and ether functionalities within its framework suggests a multifaceted role in drug design and therapeutic applications.

The synthesis and characterization of Benzeneacetic acid,4-(2-hydroxyethoxy)- have been subjects of extensive investigation, particularly in the context of developing novel bioactive molecules. The presence of both hydrophilic and lipophilic regions in its structure enhances its solubility and interaction with biological targets, making it a promising candidate for various pharmacological interventions. Recent studies have highlighted its potential in modulating signaling pathways associated with inflammation, cancer, and metabolic disorders.

In the context of contemporary research, Benzeneacetic acid,4-(2-hydroxyethoxy)- has been explored for its role as a precursor in the synthesis of more complex derivatives. These derivatives often exhibit enhanced pharmacological properties, including improved bioavailability and target specificity. The 2-hydroxyethoxy group, in particular, serves as a versatile handle for further functionalization, enabling the creation of molecules with tailored biological activities.

One of the most compelling aspects of Benzeneacetic acid,4-(2-hydroxyethoxy)- is its potential application in the development of targeted therapies. By leveraging its structural features, researchers have been able to design molecules that selectively interact with specific proteins or enzymes involved in disease pathways. For instance, studies have demonstrated its efficacy in inhibiting key enzymes implicated in tumor growth and progression. This selective interaction is crucial for minimizing side effects and improving therapeutic outcomes.

The chemical biology of Benzeneacetic acid,4-(2-hydroxyethoxy)- also intersects with the field of drug delivery systems. Its ability to form stable complexes with other molecules has been exploited to develop novel nanocarriers that enhance drug delivery efficiency. These nanocarriers can protect sensitive drugs from degradation, improve their absorption rates, and target them to specific sites within the body. Such advancements are particularly relevant in the treatment of chronic diseases where sustained drug release is essential.

Furthermore, the environmental impact of Benzeneacetic acid,4-(2-hydroxyethoxy)- has been a subject of interest. Research has shown that this compound can be biodegraded under certain conditions, reducing its environmental footprint. This characteristic is increasingly important as the pharmaceutical industry moves towards more sustainable practices. The development of environmentally friendly synthetic routes for Benzeneacetic acid,4-(2-hydroxyethoxy)- not only addresses regulatory concerns but also aligns with global efforts to minimize chemical waste.

The future prospects for Benzeneacetic acid,4-(2-hydroxyethoxy)- are promising, with ongoing research uncovering new applications and derivatives. As computational chemistry and high-throughput screening technologies advance, the discovery of novel analogs with enhanced properties is expected to accelerate. This will further expand the therapeutic potential of this compound and its derivatives across various medical conditions.

In conclusion,Benzeneacetic acid,4-(2-hydroxyethoxy)- (CAS No: 132004-29-6) stands as a significant molecule in modern chemical biology. Its unique structural features and versatile biological activities make it a valuable tool for drug discovery and development. As research continues to uncover new applications and synthetic strategies，this compound will undoubtedly play an increasingly important role in advancing therapeutic interventions.

• 104-01-8(4-Methoxyphenylacetic acid)
• 13362-94-2(2-4-(2-methylpropoxy)phenylacetic acid)
• 146031-94-9(2-[3-(propan-2-yloxy)phenyl]acetic acid)
• 4547-57-3((4-n-Butoxyphenyl)acetic acid)
• 4919-33-9(4-Ethoxyphenylacetic acid)
• 72775-83-8((3-Ethoxyphenyl)acetic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)